Fmr LLC Iovance Biotherapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 33,779 shares of IOVA stock, worth $75,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,779

Previous 82,826 59.22%

Holding current value

$75,664

Previous $275,000 78.91%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.66 - $3.61 $81,418 - $177,059	-49,047 Reduced 59.22%	33,779 $58,000
Q1 2025 May 12, 2025	SELL	$3.33 - $7.79 $115,261 - $269,635	-34,613 Reduced 29.47%	82,826 $275,000
Q4 2024 Feb 13, 2025	BUY	$7.17 - $12.28 $249,351 - $427,061	34,777 Added 42.07%	117,439 $869,000
Q3 2024 Nov 13, 2024	BUY	$7.28 - $11.9 $265,909 - $434,659	36,526 Added 79.17%	82,662 $776,000
Q2 2024 Aug 13, 2024	SELL	$7.78 - $14.19 $171,821 - $313,386	-22,085 Reduced 32.37%	46,136 $370,000
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $249,619 - $574,553	32,888 Added 93.08%	68,221 $1.01 Million
Q4 2023 Feb 13, 2024	BUY	$3.3 - $8.89 $96,185 - $259,116	29,147 Added 471.18%	35,333 $287,000
Q3 2023 Nov 13, 2023	SELL	$4.44 - $8.79 $2.08 Million - $4.12 Million	-468,502 Reduced 98.7%	6,186 $28,000
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $271,199 - $458,408	50,597 Added 11.93%	474,688 $3.34 Million
Q1 2023 May 11, 2023	BUY	$5.53 - $8.22 $2.32 Million - $3.44 Million	418,661 Added 7710.15%	424,091 $2.59 Million
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $324,352 - $577,140	-57,714 Reduced 91.4%	5,430 $34,000
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $371,698 - $511,329	-39,003 Reduced 38.18%	63,144 $605,000
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $8.27 Million - $23.7 Million	-1,295,495 Reduced 92.69%	102,147 $1.13 Million
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $7.78 Million - $12 Million	-628,524 Reduced 31.02%	1,397,642 $23.3 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $1.25 Million - $2.09 Million	75,548 Added 3.87%	2,026,166 $38.7 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $14.8 Million - $19.4 Million	-727,541 Reduced 27.17%	1,950,618 $48.1 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $43.7 Million - $88.6 Million	2,678,159 New	2,678,159 $69.7 Million

Others Institutions Holding IOVA

# of Institutions

293

Shares Held

233M

Call Options Held

1.14M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $353M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account